Search

everythinglearnresearchcommunity

for

Search:↓

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

RU58841, an androgen receptor blocker, significantly increased hair density, thickness, and length in monkeys when applied topically daily for several months.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

APKH in young males may signal early hair loss and needs early attention.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Myo-inositol with magnesium effectively reduces acne and hirsutism in PCOS patients without side effects.

Hair loss gene linked to prostate issues.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Androgens can both increase body hair and cause scalp hair loss.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

The study found genetic differences related to hair development that may explain hair loss in a patient with Trichorhinophalangeal syndrome type I.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.